GENE ONLINE|News &
Opinion
Blog

LATEST
M&A Neuroscience
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
M&A Biosimilar
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
Editors' Picks BIO CEO & Investor Digital Conference
BIO CEO 2022: How Incubators Enable Biotech Startups
2022-03-01
Trials & Approvals Cell Therapy
J&J, Legend’s Cell Therapy Gets FDA Nod
2022-03-01
Trials & Approvals Kidney Disease
EU Greenlight for Bayer’s Kidney Disease Drug, Kicking off Market Rivalry Against Established SGLT-2 Inhibitors 
2022-03-01
R&D Schizophrenia
Transcriptional Programs Uncovering the Genetic Causes of Psychiatric Disorders
2022-03-01
COVID-19 COVID-19
Plant-Based COVID-19 Vaccine Approved in Canada
2022-03-01
In-Depth UK Biobank
Big is Beautiful? What We Had Learned From The First 2 Decades of The UK Biobank
2022-02-27
Deals BIO CEO & Investor Digital Conference
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
Funding tRNA
tRNA Startup Clinches $24 Million from ARCH, Takeda and 8VC to Fix Protein Mutations
2022-02-25
Feature Digital Healthcare
UK and Taiwan to Cooperate for Breakthrough in Digital Health Innovations
2022-02-25
Funding Targeted Protein Degradation
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Asia-Pacific Gene Therapy
Takeda Taps Code Biotherapeutics to Develop Non-Viral Gene Therapies in $2 Billion Biobucks Deal
2022-02-23
Regulatory Gene Therapy
Homology Medicines Joins Biomarin in Gene Therapy Clinical Hold
2022-02-22
R&D mRNA
Moderna Unveils Three New mRNA Vaccine Programs
2022-02-21
1 … 98 99 100 101 102 … 220
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top